Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;14(2):80-87.
doi: 10.14740/jocmr4664. Epub 2022 Feb 24.

False-Positive Causes in Serum Cardiac Troponin Levels

Affiliations
Review

False-Positive Causes in Serum Cardiac Troponin Levels

Aleksey Michailovich Chaulin. J Clin Med Res. 2022 Feb.

Abstract

Cardiac troponins (cTns) are the most valuable and specific markers of cardiovascular diseases, including acute myocardial infarction. These biomarkers can also be used to assess the degree of myocardial damage in non-cardiac diseases that can negatively affect the cells of cardiac muscle tissue. However, in everyday clinical practice, doctors often encounter with false-positive cases of increased cTns. False-positive cases of increased cTns can contribute to incorrect diagnosis and subsequent inadequate treatment, which causes significant harm to the patient. This review discusses some common causes of a false-positive increase in the level of cTns in the blood serum. Such causes are fibrin clots, heterophilic antibodies, alkaline phosphatase, rheumatoid factor, and cross-reactions of diagnostic (anti-cTn) antibodies with skeletal troponins. Detailed attention is focused on the mechanisms of false-positive increase, and ways to identify and combat these false-positive causes of increased cTns. This has an important practical significance in modern clinical practice.

Keywords: Acute myocardial infarction; Biomarkers; Cardiovascular diseases; False-positive; Troponin I; Troponin T.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Figure 1
Figure 1
Possible causes of cardiac troponin elevation.

Similar articles

Cited by

References

    1. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. et al. Fourth universal definition of myocardial infarction (2018) Circulation. 2018;138(20):e618–e651. doi: 10.1161/CIR.0000000000000617. - DOI - PubMed
    1. Chaulin AM, Karslyan LS, Bazyuk EV, Nurbaltaeva DA, Duplyakov DV. [Clinical and diagnostic value of cardiac markers in human biological fluids] Kardiologiia. 2019;59(11):66–75. doi: 10.18087/cardio.2019.11.n414. - DOI - PubMed
    1. Chaulin A. Cardiac troponins: contemporary biological data and new methods of determination. Vasc Health Risk Manag. 2021;17:299–316. doi: 10.2147/VHRM.S300002. - DOI - PMC - PubMed
    1. Chaulin AM. Cardiac troponins metabolism: from biochemical mechanisms to clinical practice (Literature Review) Int J Mol Sci. 2021;22(20):10928. doi: 10.3390/ijms222010928. - DOI - PMC - PubMed
    1. Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, Dendale P. et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi: 10.1093/eurheartj/ehaa575. - DOI - PubMed

LinkOut - more resources